Search For "glenmark pharmaceuticals limited"
Glenmark's subsidiary receives NDA Approval by US FDA for Ryaltris™
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark Specialty S.A. (Switzerland), received FDA approval on its New Drug Application (NDA) fo
Read More
Glenmark Pharma reports revenue growth of 6.6% and PAT growth of 10.1% YoY
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the second quarter ended Sept 30, 2021.
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i
Read More
Glenmark Pharmaceuticals launches fixed-drug combination for management of
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
Read More
Glenmark launches Tavulus® for COPD treatment in Spain
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company today announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus® in Spa
Read More
Glenmark receives marketing approval for Ryaltris®, an innovative com
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris® in 13 countries across the EU and UK.
Read More
Glenmark receives marketing approval for Ryaltris in 13 countries across E
Updated : 4 years, 5 months ago IST
New Delhi [India] September 30 (ANI): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris in 13 countries across the EU and UK.
Read More
Glenmark Pharma reports revenue growth of 26% and PAT growth of 21% YoY fo
Updated : 4 years, 7 months ago IST
Mumbai (Maharashtra) [India], August 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2021.
Read More
Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 m
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 1 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel® Tablets, 200 mg and 400 mg of Eisai, Inc.
Read More
Glenmark's consolidated revenues grow 2.8% to Rs. 1,09,439 Mn in FY21
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 31 (ANI/PRNewswire): EBITDA growth of 22.7 per cent to Rs 20,844 Mn with margins of 19 per cent. Consolidated Net Profit of Rs 9,701 Mn with growth of 25 per cent in FY21.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection, 3
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe, the generic version of F
Read More
Glenmark launches Ryaltris®-AZ Nasal Spray for the treatment of moder
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 3 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India.
Read More